Nabriva Therapeutics plc Total Long-Term Debt
Nabriva Therapeutics plc had Total Long-Term Debt of $5.17 million as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2021-11-09
- 2021-09-30: Long-term Debt $5.17M.
- 2021-06-30: Long-term Debt $6.05M.
- 2021-03-31: Long-term Debt $5.18M.
- 2020-12-31: Long-term Debt $5.69M.
| Period end | Long-term Debt |
|---|---|
| 2021-09-30 | $5.17M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.05M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.18M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.69M 10-Q · filed 2021-11-09 |
| 2020-09-30 | $7.61M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.48M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.37M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $34.50M 10-K · filed 2021-03-11 |
| 2019-09-30 | $34.24M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $24.31M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $23.95M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $23.72M 10-K · filed 2020-03-12 |
| 2017-12-31 | $232.00K 10-K · filed 2019-03-12 |